Bhubaneswar ,2/4 ( Odisha Samachar/IMC) – The National Human Rights Commission has issued notice to Government of India seeking action taken report(ATR) over marketing of banned drugs across the country that endangers human life. Acting on a complaint of Odisha based rights activist Akhand the commission has directed Secretary of Health and family welfare and Secretary of Home to file a report in the matter within eight weeks time.
The petitioner alleged that lakhs of capsules containing a banned drug alleged to cause suicidal tendencies when abused with alcohol have reached the country’s black market. Recently, a cross-country investigation was launched by Maharastra Govt. to trace stocks of opioid painkiller dextropropoxyphene, which was banned by the health ministry on May 23, 2013.
Initiated a probe in July 2013 after 23,000 capsules of spasmo proxyvon–which contains dextropropoxyphene–were seized from Mumbai; nine thousand of these were confiscated at the international airport. During the course of the investigation, it is found that Rs 47 lakh worth of capsules containing dextropropoxyphene were bought by Mumbai dealers in late May 2013. The bulk of this–over 25 lakh capsules worth around Rs 41 lakh–was purchased by three stockiest six days after the ban.
The stockists claimed they sold the medicines to entities in Delhi, Uttar Pradesh, Bihar and Karnataka. But after inquiry, many bills proved bogus and several of the named agencies refused knowledge of placing orders. As it happens, capsules worth Rs 39 lakh are now untraceable. Three Mumbai stockiest are licensed to sell drugs exclusively to hospitals, but not a single capsule allegedly reached any hospital, alleged Akhand.
“Banned drugs are injurious to health. It endangers human life and can creates health hazards in the country. So I seeks intervention of NHRC, told Akhand.
Hearing the petition the NHRC has sought an action taken report from the Health and Home Department of Union Government over the issue within two months .